tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Chemomab Therapeutics appoints Weiner as interim CMO, Lawler as CDO

Chemomab Therapeutics (CMMB) announced that David Weiner, MD, has been named Interim Chief Medical Officer, CMO, and Jack Lawler, Senior Vice President of Global Medical Operations at Chemomab, has been named Chief Development Officer, CDO.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1